Host Defense and Bacterial Pneumonia

Seminars in Respiratory and Critical Care Medicine

Volumn 25, Issue 1, 2004, Pages 43-52

  Happel, Kyle I ^a   Bagby, Gregory J ^a   Nelson, Steve ^a  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alcohol; Cytokines; Host defense; Inflammation; Pneumonia

Indexed keywords

ALCOHOL; CYTOKINE; PEPTIDE;

ALCOHOLISM; ANATOMY; ANTIGEN SPECIFICITY; ANTIMICROBIAL ACTIVITY; BACTERIAL PNEUMONIA; CELL MIGRATION; CILIATED EPITHELIUM; CYTOKINE RELEASE; HOST RESISTANCE; HUMAN; IMMUNE SYSTEM; INFLAMMATION; LOWER RESPIRATORY TRACT; LUNG ALVEOLUS MACROPHAGE; LUNG FLUID; NEUTROPHIL; NONHUMAN; PHAGOCYTE; PRIORITY JOURNAL; REVIEW;

EID: 1542273545     PISSN: 10693424     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-822304     Document Type: Review

References (45)

1. Tenovuo J. Antimicrobial agents in saliva-protection for the whole body. J Dent Res 2002;81:807-809
2. Afzelius BA. A human syndrome caused by immotile cilia. Science 1976;193:317-319
3. Mandell GBJDR. Principles and Practice of Infectious Diseases. 5th ed. Oxford: Churchill Livingstone; 2000
4. Zaiou M, Gallo RL. Cathelicidins, essential gene-encoded mammalian antibiotics. J Mol Med 2002;80:549-561
5. Le Y, Yang Y, Cui Y, et al. Receptors for chemotactic formyl peptides as pharmacological targets. Int Immunopharmacol 2002;2:1-13
6. Shepherd VL. Pulmonary surfactant protein D: a novel link between innate and adaptive immunity. Am J Physiol Lung Cell Mol Physiol 2002;282:L516-L517
7. Medzhitov R. Toll-like receptors and innate immunity. Nat Rev Immunol 2001;1:135-145
8. Carswell EA, Old LJ, Kassel RL, et al. An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci USA 1975;72:3666-3670
9. Ulich TR, Watson LR, Yin SM, et al. The intratracheal administration of endotoxin and cytokines, I: Characterization of LPS-induced IL-1 and TNF mRNA expression and the LPS-, IL-1, and TNF-induced inflammatory infiltrate. Am J Pathol 1991;138:1485-1496
10. Nelson S, Bagby GJ, Mason C, Summer W. Cytokines and the antibacterial defenses of the lung. In: Nelson S, Martin T, eds. Cytokines in Pulmonary Diseases. New York: Marcel Dekker; 2000:131-148
11. Kolls JK, Lei D, Nelson S, et al. Adenovirus-mediated blockade of tumor necrosis factor in mice protects against endotoxic shock yet impairs pulmonary host defense. J Infect Dis 1995;171:570-575
12. Wunderink RG, Waterer GW, Cantor RM, Quasney MW. Tumor necrosis factor gene polymorphisms and the variable presentation and outcome of community-acquired pneumonia. Chest 2002;121:87S
13. Stephens KE, Ishizaka A, Larrick JW, Raffin TA. Tumor necrosis factor causes increased pulmonary permeability and edema: comparison to septic acute lung injury. Am Rev Respir Dis 1988;137:1364-1370
14. 2-generation by rabbit alveolar macrophages. J Biochem (Tokyo) 1980;87:1449-1455
15. Mizgerd JP, Meek BB, Kutkoski GJ, et al. Selectins and neutrophil traffic: margination and Streptococcus pneumoniae-induced emigration in murine lungs. J Exp Med 1996;184:639-645
16. Doerschuk CM. Leukocyte trafficking in alveoli and airway passages. Respir Res 2000;1:136-140
17. Doerschuk CM, Mizgerd JP, Kubo H, Qin L, Kumasaka T. Adhesion molecules and cellular biomechanical changes in acute lung injury. Giles F. Filley Lecture. Chest. 1999;116:37S-43S
18. Wagner JG, Roth RA. Neutrophil migration mechanisms, with an emphasis on the pulmonary vasculature. Pharmacol Rev 2000;52:349-374
19. Kunkel SL, Standiford T, Kasahara K, Strieter RM. Interleukin-8 (IL-8): the major neutrophil chemotactic factor in the lung. Exp Lung Res 1991;17:17-23
20. Kunkel SL, Standiford T, Kasahara K, Strieter RM. Interleukin-8 (IL-8): the major neutrophil chemotactic factor in the lung. Exp Lung Res 1991;17:17-23
21. Greenberger MJ, Strieter RM, Kunkel SL, et al. Neutralization of macrophage inflammatory protein-2 attenuates neutrophil recruitment and bacterial clearance in murine Klebsiella pneumonia. J Infect Dis 1996;173:159-165
22. Boutten A, Dehoux MS, Seta N, et al. Compartmentalized IL-8 and elastase release within the human lung in unilateral pneumonia. Am J Respir Crit Care Med 1996;153:336-342
23. Bonten MJ, Froon AH, Gaillard CA, et al. The systemic inflammatory response in the development of ventilator-associated pneumonia. Am J Respir Crit Care Med 1997;156:1105-1113
24. Nelson S, Bagby GJ, Bainton BG, et al. Compartmentalization of intraalveolar and systemic lipopolysaccharide-induced tumor necrosis factor and the pulmonary inflammatory response. J Infect Dis 1989;159:189-194
25. Dale DC, Liles WC, Summer WR, Nelson S. Review: granulocyte colony-stimulating factor: role and relationships in infectious diseases. J Infect Dis 1995;172:1061-1075
26. Tazi A, Nioche S, Chastre J, Smiejan JM, Hance AJ. Spontaneous release of granulocyte colony-stimulating factor (G-CSF) by alveolar macrophages in the course of bacterial pneumonia and sarcoidosis: endotoxin-dependent and endotoxin-independent G-CSF release by cells recovered by bronchoalveolar lavage. Am J Respir Cell Mol Biol 1991;4:140-147
27. Nelson S, Bagby GJ. Granulocyte colony-stimulating factor and modulation of inflammatory cells in sepsis. Clin Chest Med 1996;17:319-332
28. Nelson S, Belknap SM, Carlson RW, et al. A randomized controlled trial of filgrastim as an adjunct to antibiotics for treatment of hospitalized patients with community-acquired pneumonia. CAP Study Group. J Infect Dis 1998;178:1075-1080
29. Aggarwal S, Gurney AL. IL-17: prototype member of an emerging cytokine family. J Leukoc Biol 2002;71:1-8
30. Happel KI, Zheng M, Young E, et al. Cutting edge: roles of Toll-like receptor 4 and IL-23 in IL-17 expression in response to Klebsiella pneumoniae infection. J Immunol 2003;170:4432-4436
31. Yao Z, Painter SL, Fanslow WC, et al. Human IL-17: a novel cytokine derived from T cells. J Immunol 1995;155:5483-5486
32. Lankford CS, Frucht DM. A unique role for IL-23 in promoting cellular immunity. J Leukoc Biol 2003;73:49-56
33. Standiford TJ, Kunkel SL, Greenberger MJ, Laichalk LL, Strieter RM. Expression and regulation of chemokines in bacterial pneumonia. J Leukoc Biol 1996;59:24-28
34. van der Poll T, Marchant A, Keogh CV, Goldman M, Lowry SF. Interleukin-10 impairs host defense in murine pneumococcal pneumonia. J Infect Dis 1996;174:994-1000
35. Gallagher PM, Lowe G, Fitzgerald T, et al. Association of IL-10 polymorphism with severity of illness in community acquired pneumonia. Thorax 2003;58:154-156
36. Cuzzocrea S, Mazzon E, Dugo L, et al. Absence of endogenous interleukin-10 enhances the evolution of acute lung injury. Eur Cytokine Netw 2002;13:285-297
37. Puren AJ, Feldman C, Savage N, Becker PJ, Smith C. Patterns of cytokine expression in community-acquired pneumonia. Chest 1995;107:1342-1349
38. Ortqvist A, Hedlund J, Wretlind B, Carlstrom A, Kalin M. Diagnostic and prognostic value of interleukin-6 and C-reactive protein in community-acquired pneumonia. Scand J Infect Dis 1995;27:457-462
39. Antunes G, Evans SA, Lordan JL, Frew AJ. Systemic cytokine levels in community-acquired pneumonia and their association with disease severity. Eur Respir J 2002;20:990-995
40. Marik PE. The clinical features of severe community-acquired pneumonia presenting as septic shock. Norasept II Study Investigators. J Crit Care 2000;15:85-90
41. Bonten MJ, Froon AH, Gaillard CA, et al. The systemic inflammatory response in the development of ventilator-associated pneumonia. Am J Respir Crit Care Med 1997;156:1105-1113
42. Monton C, Torres A, El Ebiary M, et al. Cytokine expression in severe pneumonia: a bronchoalveolar lavage study. Crit Care Med 1999;27:1745-1753
43. Schmidt W, De Lint J. Causes of death of alcoholics. QJ Stud Alcohol 1972;33:171-185
44. Saitz R, Ghali WA, Moskowitz MA. The impact of alcohol-related diagnoses on pneumonia outcomes. Arch Intern Med 1997;157:1446-1452
45. Zisman DA, Strieter RM, Kunkel SL, et al. Ethanol feeding impairs innate immunity and alters the expression of Th1- and Th2-phenotype cytokines in murine Klebsiella pneumonia. Alcohol Clin Exp Res 1998;22:621-627